Cargando...

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.

The effect has been studied of adding either misonidazole (MISO) or the radioprotective drug, WR 2721, to cyclophosphamide (CY) treatment of mice bearing either the RIF-1 or KHT sarcomas. In RIF-1, the growth delay due to CY was increased by the addition of 1 mg/g of MISO. At doses below 75 mg/kg of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Twentyman, P. R.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 1981
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010713/
https://ncbi.nlm.nih.gov/pubmed/6264941
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!